Big three hospitals selling | 'Tian price' | supplies, departments collective recovery button, Xinhua News Agency issued an exposure!

Medical Network September 14th In the current era of consumables collection and reduction of prices, there is such a consumable product, the purchase price of 260 yuan was sold to the top three hospitals to 2,650 yuan, Xinhua News Agency published.

On September 12, according to a survey report by Xinhua Viewpoint, the staff of the Old People's Hospital of Jiangsu Province recommended the purchase of high-priced orthopedic foot pads. The price of this custom insole is 2,650 yuan in the hospital.

'The price is 2,650 yuan a pair, can't bargain, is the health department decided to die.' The nurse gave the reporter an insole printed with the 'Dao Ke De' trademark. The package shows that its manufacturer is Nanjing Dao Kede Medical Technology Service. Ltd. A Jiangsu Provincial People's Hospital outpatient fee bill shows that the price of two pairs of 'thermoplastic foot orthopedic aids' is 5,300 yuan.

The report also mentioned that the hospital's medical staff can get a 200 yuan commission for every pair sold.

According to the official website of the People's Hospital of Jiangsu Province, the Department of Traditional Rehabilitation of the Department of the Elderly involved in the Department of Physical Education, focusing on spine-related diseases, gait correction, sports rehabilitation and other fields. Hu Moumou is an expert in this department, Jiangsu Provincial People's Hospital Geriatrics Medical Center Director, Director of the Spine Disease Rehabilitation Center of Jiangsu Provincial People's Hospital.

The National Enterprise Credit Information Publicity System shows that the company’s business scope includes health Consulting, one class, two class medical instruments , office supplies, furniture, etc.

According to common sense, the cost of such an expensive insole should be very high. However, the report quoted a person familiar with the matter, the cost of the cost may be only 200 yuan.

'A pair of insoles can reach more than 2,000 yuan.' According to a manager of Jiangsu Suyun Medical Equipment Co., Ltd., the custom insole of Dowco is processed on the basis of the 'insole embryo' of Jiangsu Suyun Medical Equipment Co., Ltd. They have a supply price of 260 yuan for Dowco's insole. If the order quantity exceeds 10,000, they will also enjoy a rebate of 5%-8%.

Next, the suffocating operation came: 260 yuan to buy semi-finished products, find an office to rent a studio, equipment investment of 70,000,000, a few people can operate.

'Equipment investment is about 70,000 yuan, and a few people can be hired to operate.' The above-mentioned insiders introduced that the threshold for setting up a similar custom orthopedic insole is very low. In order to create a 'professional' for patients, 'trust Sense', the studio can hang the '××Biomechanical Orthopaedic Center' brand, and even open the studio to the hospital, let the salesman put on the white coat to promote sales.

A staff member of the Tender Management Office of the People's Hospital of Jiangsu Province indicated to Xinhua that the orthopedic insoles are consumables and are purchased separately. When asked where they can be viewed, the staff member is not clear.

In this 'unclear' situation, it is not known that department heads and medical staff receive kickbacks, and the head of the department has a close relationship with the insole company.

According to the report, two copies of the 'orthopaedic insole production fee list' from Dow can be found. There are 9 medical staff of Jiangsu Provincial People's Hospital participating in the commission. The monthly commission table also includes a list of patients with customized insoles.

The list is only listed, and the specific commission fee is not listed. The insider revealed that this is to prevent the total amount of information from being leaked. The commission also shows that the director of the department, Hu Moumou, has the most recommended number, and the recommended number of one month is 38 pairs. A commission in December 2017 showed that 61 pairs of insoles were sold in the month. 'A top three hospital can sell thousands of pairs a year.' He said.

'Tianyancha' shows that Hu Moumou and Li are both shareholders of another health management company, and the two are partners. Li is the second largest shareholder of Daokede.

At the moment when the national consumables are collecting and cutting prices, how much consumables manufacturers are self-proclaimed.

We must know that the Jiangsu province's consumables collection and mining prices are linked to the moment, many consumables enterprise In order to keep the market, they have to cut prices again and again. The above-mentioned staff called the 'single centralized procurement', and the cypress blue equipment editors inquire about the people of Jiangsu Province. hospital The official website, did not find such notice. (Tender The professionals in the management office don’t know where to look, but a small editor should not check it.)

However, the report quoted the staff of the procurement center of a public top three hospital in Nanjing as saying that the orthopaedic aids entering public hospitals should be standardized and included in the bidding catalogue. The hospitals should purchase the bids according to actual needs and go through the official website. Publicity, accepting social supervision. The implication is that orthopedic aids have not been included in the bidding catalogue, at least not in the bidding catalogue prepared by the People's Hospital of Jiangsu Province, and the official website of the hospital has not been publicized.

In fact, Cypress Blue Instruments has learned that there is no 'single centralized procurement' in the current six procurement models. The public bidding procurement is not in the first place, and the GPO model is even more difficult to talk about. Cross-regional joint procurement is also far removed. The Chongqing drug exchange model and the procurement model combined with Fujian and medical insurance do not contain a single statement. Only 'direct net procurement' is similar to the meaning, but it is obvious that the two are essentially different.

Cypress Blue equipment inquires about the relevant policy documents of medical equipment procurement in Nanjing, one of which is reflected in the small series: On December 25, 2017, the Nanjing Municipal Health Planning Commission issued the “Nanjing City on Further Strengthening the Management of Medical Device Purchasing in Medical Institutions”. Notice of the Ministry of Health, which refers to the procurement of large and medium-sized medical equipment in accordance with the Interim Provisions on Strengthening the Management of Large and Medium-sized Medical Equipment. The procurement of medical consumables and reagents is in accordance with the medical treatment of Nanjing Medical and Health Organization. The Measures for the Management of Consumables implements online centralized procurement.

Purchasing of other medical devices shall be carried out in accordance with the requirements of this notice. Among them, medical devices with a unit price of less than 10,000 yuan or a batch amount of less than 50,000 yuan shall be submitted by the department of use and submitted to the medical equipment management department for preliminary examination. The main leadership of the unit is approved, and the medical equipment procurement department of the medical institution purchases it uniformly.

Medical devices with a unit price of 10,000 yuan or more or a batch amount of 50,000 yuan or more to less than 100,000 yuan shall be included in the annual procurement plan management. The procurement plan shall be submitted by the use department, and the medical equipment management department shall summarize and be managed by medical equipment. After discussion and approval by the committee, the main leaders of the reporting unit will be included in the annual procurement plan and will be uniformly purchased by the medical device procurement department of the medical institution.

However, as for how the 'individual centralized procurement' operation, only the director of the department, Hu Moumou, said it was clear.

In the early morning of September 13, Jiangsu Provincial People's Hospital issued a response on the matter on the official website, saying that the Party Committee and the Disciplinary Committee of the Institute quickly formed a special working group, and organized special personnel to conduct comprehensive and in-depth investigations according to the law. The head of the department, Hu Zhihong, immediately suspended the cooperation. Investigation, suspension of outpatient and other work, according to further investigation, and then deal with it accordingly.

At the same time, the hospital said that it immediately stopped using and purchased the orthopedic foot pad products of Nanjing Dao Ke De Medical Technology Service Co., Ltd. to cooperate with the investigation.